Troy D. Querec

3.4k total citations · 1 hit paper
48 papers, 2.3k citations indexed

About

Troy D. Querec is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Troy D. Querec has authored 48 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 24 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Troy D. Querec's work include Cervical Cancer and HPV Research (33 papers), Genital Health and Disease (23 papers) and Hepatitis B Virus Studies (20 papers). Troy D. Querec is often cited by papers focused on Cervical Cancer and HPV Research (33 papers), Genital Health and Disease (23 papers) and Hepatitis B Virus Studies (20 papers). Troy D. Querec collaborates with scholars based in United States, France and Belgium. Troy D. Querec's co-authors include Bali Pulendran, Elizabeth R. Unger, Rafi Ahmed, Soumaya Bennouna, Lauri E. Markowitz, Julia W. Gargano, Rayleen M. Lewis, Richard A. Flavell, Yasmina Laouar and Shizuo Akira and has published in prestigious journals such as The Journal of Experimental Medicine, Annals of Internal Medicine and Nature Immunology.

In The Last Decade

Troy D. Querec

45 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

2008 809 citations Troy D. Querec, Soumaya Bennouna et al. profile →

Peers

Countries citing papers authored by Troy D. Querec

Since Specialization

Citations

This map shows the geographic impact of Troy D. Querec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy D. Querec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy D. Querec more than expected).

Fields of papers citing papers by Troy D. Querec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troy D. Querec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy D. Querec. The network helps show where Troy D. Querec may publish in the future.

Co-authorship network of co-authors of Troy D. Querec

This figure shows the co-authorship network connecting the top 25 collaborators of Troy D. Querec. A scholar is included among the top collaborators of Troy D. Querec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Troy D. Querec. Troy D. Querec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical effectiveness of HPV vaccine by age at vaccination: a matched case-control study 2025 ·The Lancet Regional Health - Americas ·Carlos R. Oliveira, (unknown), Sangini S. Sheth, Mallory K. Ellingson, (unknown), (unknown), Troy D. Querec, Elizabeth R. Unger, Linda M. Niccolai	0
2	Evaluation of possible human papillomavirus (HPV) type replacement after vaccine introduction, overall and by race/ethnicity, United States 2025 ·Vaccine ·Sarah Brewer, Rayleen M. Lewis, Troy D. Querec, Elizabeth R. Unger, Lauri E. Markowitz	1
3	Vaccine Effectiveness Against Anal HPV Infection Among Men With HIV Who Have Sex With Men Attending Sexual Health Clinics in Three US Cities, 2018–2023 2025 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Carla L. DeSisto, (unknown), Preeti Pathela, Rachel L. Winer, Lenore Asbel, Troy D. Querec, John Lin, Jennifer Tang, (unknown), Elissa Meites, Elizabeth R. Unger, Lauri E. Markowitz	1
4	High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 2024 ·Human Vaccines & Immunotherapeutics ·(unknown), Rayleen M. Lewis, Troy D. Querec, Julia W. Gargano, Elizabeth R. Unger, Lauri E. Markowitz	6
5	A human papillomavirus whole genome plasmid repository: A resource for HPV DNA quality control reagents 2023 ·Journal of Clinical Virology ·Hem R. Thapa, Elizabeth R. Unger, Troy D. Querec	2
6	Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018 2022 ·Annals of Internal Medicine ·Hannah G. Rosenblum, Rayleen M. Lewis, Julia W. Gargano, Troy D. Querec, Elizabeth R. Unger, Lauri E. Markowitz	40
7	HPV type‐specific trends in cervical precancers in the United States, 2008 to 2016 2022 ·International Journal of Cancer ·Julia W. Gargano, Nancy McClung, Rayleen M. Lewis, Ina U. Park, Erin Whitney, Jessica L. Castilho, (unknown), Linda M. Niccolai, Monica Brackney, Emilio DeBess, (unknown), Nancy M. Bennett, Mary Scahill, Angela A. Cleveland, Troy D. Querec, Elizabeth R. Unger, Lauri E. Markowitz, (unknown)	19
8	HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring 2022 ·BMC Infectious Diseases ·Nancy McClung, (unknown), Julia W. Gargano, (unknown), Troy D. Querec, (unknown), Madisa Mine, Chelsea Morroni, Rebecca Luckett, Lauri E. Markowitz, Doreen Ramogola‐Masire	8
9	Prevalence of human papillomavirus genotypes in high‐grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States 2021 ·Cancer ·Jacqueline Mix, Mona Saraiya, Trevor Thompson, Troy D. Querec, April Greek, T. C. Tucker, Edward Peters, Charles F. Lynch, Brenda Y. Hernandez, Glenn Copeland, Marc T. Goodman, Elizabeth R. Unger	5
10	Evaluation of natural killer cell assay performance on shipped blood specimens 2021 ·Journal of Immunological Methods ·Troy D. Querec, Joseph Y. Abrams, Jennifer J. Stewart, Zachary Barnes, Elizabeth Balbin, Nancy G. Klimas, Mary A Fletcher, Lynette Brown, Jeanne Bertolli, Elizabeth R. Unger	4
11	An Isothermal, Multiplex Amplification Assay for Detection and Genotyping of Human Papillomaviruses in Formalin-Fixed, Paraffin-Embedded Tissues 2020 ·Journal of Molecular Diagnostics ·Yi‐Wei Tang, (unknown), Xin Chen, Troy D. Querec, Nora Katabi, Antonio Moreno‐Docón, Hongmei Wang, Daniel Fix, Louise De Brot, Tracy McMillen, Ju‐Yoon Yoon, (unknown), Youxiang Wang, Elizabeth R. Unger, Kay J. Park	24
12	Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination 2019 ·Vaccine ·Lauri E. Markowitz, Allison L. Naleway, Rayleen M. Lewis, Bradley Crane, Troy D. Querec, Sheila Weinmann, Martin Steinau, Elizabeth R. Unger	42
13	Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey 2019 ·Journal of Adolescent Health ·Nancy McClung, Rayleen M. Lewis, Julia W. Gargano, Troy D. Querec, Elizabeth R. Unger, Lauri E. Markowitz	32
14	Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types 2014 ·Journal of Immunological Methods ·Gitika Panicker, (unknown), Brian M. Gurbaxani, Troy D. Querec, Elizabeth R. Unger	43
15	Randomization Modeling to Ascertain Clustering Patterns of Human Papillomavirus Types Detected in Cervicovaginal Samples in the United States 2013 ·PLoS ONE ·Troy D. Querec, Brian M. Gurbaxani, Elizabeth R. Unger	3
16	Understanding the Role of Innate Immunity in the Mechanism of Action of the Live Attenuated Yellow Fever Vaccine 17D 2007 ·Advances in experimental medicine and biology ·Troy D. Querec, Bali Pulendran	23
17	Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity 2006 ·The Journal of Experimental Medicine ·Troy D. Querec, Soumaya Bennouna, (unknown), Yasmina Laouar, (unknown), Richard A. Flavell, Shizuo Akira, Rafi Ahmed, Bali Pulendran	416
18	Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia 2004 ·Cancer Research ·Sherri L. Stewart, Troy D. Querec, (unknown), (unknown), Rudi Bao, James S. Babb, (unknown), (unknown), (unknown), Andres J. Klein–Szanto, Thomas C. Hamilton, Christos Patriotis	52
19	Normalization of single-channel DNA array data by principal component analysis 2004 ·Bioinformatics ·Radka Stoyanova, Troy D. Querec, Truman R. Brown, Christos Patriotis	20
20	A novel approach for increasing sensitivity and correcting saturation artifacts of radioactively labeled cDNA arrays 2004 ·Bioinformatics ·Troy D. Querec, Radka Stoyanova, Eric A. Ross, Christos Patriotis	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact